Dear readers, Niacin is the “red-headed stepchild” of lipid-lowering options in 2025, but one I use liberally in my preventive clinic. A new paper in…

Dear readers, Although I prefer to write about broccoli sprouts, advances in pharmaceutical approaches to heart disease cannot be ignored, and this week was a…

Dear readers, If you are a Jimmy Buffett fan, you may know one of his last songs, Bubbles Up. A new analysis of predictors of…

Dear readers, A big week of health news, starting with a promising study that shows targeting the endothelial glycocalyx with natural products (no Rx products…

Dear readers, With heart disease remaining the #1 cause of death in the world, we need an all-out attack on heart attacks. Black adults in…

Dear readers, If we want to #MAHA, we should label bacon, hot dogs, and sausages with a warning label for dementia and heart disease. Agree?…

Dear readers, Let the screaming begin! Another major study reports low cholesterol levels are related to a lower risk of dementia and that statin Rx…

Dear readers, In all humility, my patients who need lipid-lowering therapy (LLT) have been getting 2 Rx for years: a statin at a low dose…

Dear readers, Over 90 years ago, fatty acids were determined to be essential in the diet for optimal health. The word is not out, however,…